The role of a neurologist in deciding on the treatment options in epilepsy: therapy and/or surgery
https://doi.org/10.17749/2077-8333.2019.11.3.286-292
Abstract
About the Authors
K. V. VoronkovaRussian Federation
Kira V. Voronkova – MD, PhD, Professor at the Department of Neurology
1 Ostrovityanova Str., Moscow 117997, Russia;
1A Litovsky Boulevard, Moscow 117593, Russia
A. I. Fedin
Russian Federation
Anatoly I. Fedin – MD, PhD, Professor and Head, Department of Neurology
1 Ostrovityanova Str., Moscow 117997, Russia
A. E. Nikitin
Russian Federation
Aleksei E. Nikitin – MD, PhD, Professor, Chief Physician at the Central Clinical Hospital of the Russian Academy of Sciences
1A Litovsky Boulevard, Moscow 117593, Russia
A. A. Zuev
Russian Federation
Andrei A. Zuev – MD, PhD, Head, Department of Neurosurgery
70, Nizhnyaya Pervomayskaya Str., Moscow 105203, Russia
N. V. Pedyash
Russian Federation
Nikita V. Pedyash – MD, Neurosurgeon, Department of Neurosurgery
70, Nizhnyaya Pervomayskaya Str., Moscow 105203, Russia
D. M. Bochaeva
Russian Federation
Diana M. Bochaeva – MD, PhD Student, Department of Neurology
1 Ostrovityanova Str., Moscow 117997, Russia;
1A Litovsky Boulevard, Moscow 117593, Russia
References
1. Brodie M.J., Kwan P. Staged approach to epilepsy management. Neurology. 2002; 58 (5): 2-8.
2. Kwan P. et al. Definition of drug resistant epilepsy. Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010; 51 (6): 1069-77.
3. Voronkova K.V., Petrukhin A.S. et al. Rational antiepileptic pharmacotherapy. Guide for doctors. 2008; 192 s. (in Russ.).
4. Benbadis Selim R. et al. Epilepsy and Seizures Treatment & Management. 2016.
5. Bernasconi A. et al. Recommendations for the use of structural magnetic resonance imaging in the care of patients with epilepsy: A consensus report from the International League Against Epilepsy Neuroimaging. Task Force. Epilepsia. 2019; 60: 1054-1068.
6. Richardson M. Update on neuroimaging in epilepsy. Expert Rev. Neurother. 2010; 10 (6): 961-73.
7. Bernasconi A., Bernasconi N., Bernhardt B.C., et al. Advances in MRI for ‘cryptogenic’ epilepsies. Nat. Rev. Neurol. 2011; 7 (2): 99-108.
8. Craven I., Kotsarini C., Hoggard N. Recent advances in imaging epilepsy. Postgrad Med. J. 2010; 86 (1019): 552-9.
9. Jehi L., Mathern G.W. Who’s responsible to refer for epilepsy surgery? We all are! Neurology. 2015; 84: 112-3.
10. Roberts J. I., Hrazdil C., Wiebe S., et al. Neurologists’ knowledge of and attitudes toward epilepsy surgery: a national survey. Neurology. 2015; 84: 159-66.
11. J. von Oertzen, Urbach H., Jungbluth S., Kurthen M., Reuber M., Fernández G., Elger C. E. Standard magnetic resonance imaging is inadequate for patients with refractory focal epilepsy. J. Neurol. Neurosurg. Psychiatry. 2002; 73 (6): 643-647.
12. Clinical recommendations for preoperative examination and surgical treatment of patients with pharmacologically resistant forms of epilepsy. Approved at the Plenum of the Board of the Association of Neurosurgeons of Russia. Kazan. 2015; (in Russ.).
13. Kwan P. et al. Definition of drug resistant epilepsy. Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010; 51 (6): 1069-77.
14. Aivazyan S.O., Lukyanova E.G., Shiryaev Y.S. Modern treatment options for drug-resistant epilepsy in children. Epilepsia i paroksizmalʹnye sostoania / Epilepsy and Paroxysmal Conditions. (In Russ.). 2014; 6 (1): 34-43.
15. Kwan P., Brodie M. J. Effectiveness of first antiepileptic drug. Epilepsia. 2001; 42: 1255-60.
16. Voronkova K.V., Nikitin A. E., Rudakova I.G., Vlasov P.N., Burd S.G., Lebedeva A.V., Avakyan G.N. Today’s choice of antiepileptic therapy: stages and recommendations. Epilepsia i paroksizmalʹnye sostoania / Epilepsy and Paroxysmal Conditions. (In Russ.) 2018; 10 (2): 74-82. DOI: 10.17749/2077-8333.2018.10.2.074-081.
17. Karlov V.A. at al. Algorithms of mono- and polytherapy in clinical epileptology. Part 1. General principles of drug choice. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova (In Russ.). 2016; 6 (1): 109-114. DOI: 10.17116/jnevro201611661109-114.
18. Karlov V.A. at al. Algorithms of mono- and polytherapy in clinical epileptology. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova (In Russ.). 2016; 116 (7): 120-129. DOI: 10.17116/jnevro201611671120-129.
19. Vaz-Carneiro A. et al. Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: a systematic review and metaanalysis. Epilepsia. 2011; 52 (7): 1528-1167.
Review
For citations:
Voronkova K.V., Fedin A.I., Nikitin A.E., Zuev A.A., Pedyash N.V., Bochaeva D.M. The role of a neurologist in deciding on the treatment options in epilepsy: therapy and/or surgery. Epilepsy and paroxysmal conditions. 2019;11(3):286-292. (In Russ.) https://doi.org/10.17749/2077-8333.2019.11.3.286-292

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.